Placental implications of peroxisome proliferator-activated receptors in gestation and parturition

PPAR Research

Volumn , Issue , 2008, Pages

  Borel, Valerie ^a,b   Gallot, Denis ^a,c   Marceau, Geoffroy ^a,b   Sapin, Vincent ^a,b   Blanchon, Loïc ^a,b  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b INSERM   (France)

^c HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

AMNION; FETUS MEMBRANE; HUMAN; INFLAMMATION; LIPID TRANSPORT; METABOLIC DISORDER; NONHUMAN; PREGNANCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

EID: 38649116900     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2008/758562     Document Type: Review

References (59)

1. W. T. Schaiff Y. Barak Y. Sadovsky The pleiotropic function of PPAR γ in the placenta. Molecular and Cellular Endocrinology 249 2006 1-2 10 15
2. P. Froment froment@lyon.inserm.fr F. Gizard D. Defever B. Staels J. Dupont P. Monget Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition. Journal of Endocrinology 189 2 2006 199 209
3. T. Fournier V. Tsatsaris K. Handschuh D. Evain-Brion evain@pharmacie. univ-paris5.fr PPARs and the placenta. Placenta 28 2-3 2007 65 76
4. I. Issemann S. Green Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347 6294 1990 645 650
5. L. Michalik B. Desvergne C. Dreyer M. Gavillet R. N. Laurini W. Wahli PPAR expression and function during vertebrate development. International Journal of Developmental Biology 46 1 2002 105 114
6. L. Fajas D. Auboeuf E. Raspe The organization, promoter analysis, and expression of the human PPARγ gene. The Journal of Biological Chemistry 272 1997 30 18779 18789
7. P. Escher W. Wahli walter.wahli@iba.unil.ch Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutation Research 448 2 2000 121 138
8. B. Desvergne W. Wahli Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocrine Reviews 20 1999 5 649 688
9. V. Y. Ng Y. Huang L. M. Reddy J. R. Falck E. T. Lin D. L. Kroetz Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor α Drug Metabolism and Disposition 35 2007 7 1126 1134
10. P. Escher O. Braissant S. Basu-Modak L. Michalik W. Wahli B. Desvergne Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding. Endocrinology 142 10 2001 4195 4202
11. Q. Wang H. Fujii G. T. Knipp gknipp@cop.rutgers.edu Expression of PPAR and RXR isoforms in the developing rat and human term placentas. Placenta 23 8-9 2002 661 671
12. E. B. E. Berry ebe.berry@auckland.ac.nz R. Eykholt R. J. A. Helliwell R. S. Gilmour M. D. Mitchell K. W. Marvin Peroxisome proliferator-activated receptor isoform expression changes in human gestational tissues with labor at term. Molecular Pharmacology 64 6 2003 1586 1590
13. B. E. Schwarz F. M. Schultz P. C. Macdonald J. M. Johnston Initiation of human parturition. III. fetal membrane content of prostaglandin E2 and F2α precursor. Obstetrics and Gynecology 46 1975 5 564 568
14. J. R. Okita P. C. MacDonald J. M. Johnston Mobilization of arachidonic acid from specific glycerophospholipids of human fetal membranes during early labor. Journal of Biological Chemistry 257 23 1982 14029 14034
15. M. D. Mitchell D. L. Kraemer D. M. Strickland The human placenta: a major source of prostaglandin D 2. Prostaglandins Leukotrienes and Medicine 8 4 1982 383 387
16. R. J. Helliwell J. A. Keelan K. W. Marvin Gestational age-dependent up-regulation of prostaglandin D synthase (PGDS) and production of PGDS-derived antiinflammatory prostaglandins in human placenta. Journal of Clinical Endocrinology & Metabolism 91 2006 2 597 606
17. L. L. Waite E. C. Person Y. Zhou K. H. Lim T. S. Scanlan R. N. Taylor Placental peroxisome proliferator-activated receptor-γ is up-regulated by pregnancy serum. Journal of Clinical Endocrinology & Metabolism 85 2000 10 3808 3814
18. H. Li X. Z. Ruan S. H. Powis EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-γ-dependent mechanism. Kidney International 67 2005 3 867 874
19. A. De Paulis A. Ciccarelli I. Marinò G. De Crescenzo D. Marinò G. Marone Human synovial mast cells: II. heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs. Arthritis and Rheumatism 40 3 1997 469 478
20. H. Fahmi J. A. Di Battista J. P. Pelletier F. Mineau P. Ranger J. Martel-Pelletier Peroxisome proliferator-activated receptor γ activators inhibit interleukin-1β-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes. Arthritis & Rheumatism 44 2001 3 595 607
21. Y. Barak M. C. Nelson E. S. Ong PPAR γ is required for placental, cardiac, and adipose tissue development. Molecular Cell 4 1999 4 585 595
22. V. Sapin L. Blanchon A. F. Serre D. Lemery B. Dastugue S. J. Ward Use of transgenic mice model for understanding the placentation: towards clinical applications in human obstetrical pathologies? Transgenic Research 10 2001 5 377 398
23. P. Antonson per.antonsonr@cbt.ki.se G. U. Schuster L. Wang Inactivation of the nuclear receptor coactivator RAP250 in mice results in placental vascular dysfunction. Molecular and Cellular Biology 23 4 2003 1260 1268
24. Y. Zhu C. Qi Y. Jia J. S. Nye M. S. Rao J. K. Reddy jkreddy@nwu.edu Deletion of PBP/PARBP, the gene for nuclear receptor coactivator peroxisome proliferator-activated receptor-binding protein, results in embryonic lethality. Journal of Biological Chemistry 275 20 2000 14779 14782
25. Y.-J. Zhu S. E. Crawford V. Stellmach Coactivator PRIP, the peroxisome proliferator-activated receptor-interacting protein, is a modulator of placental, cardiac, hepatic, and embryonic development. Journal of Biological Chemistry 278 3 2003 1986 1990
26. Y. Barak D. Liao W. He Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer. Proceedings of the National Academy of Sciences of the United States of America 99 2002 1 303 308
27. W. T. Schaiff F. F. Knapp Jr. Y. Barak T. Biron-Shental D. M. Nelson Y. Sadovsky Ligand-activated PPARγ alters placental morphology and placental fatty acid uptake in mice. Endocrinology 148 2007 8 3625 3634
28. W. T. Schaiff I. Bildirici M. Cheong P. L. Chern D. M. Nelson Y. Sadovsky ysadovsky@wustl.edu Peroxisome proliferator-activated receptor-γ and retinoid X receptor signaling regulate fatty acid uptake by primary human placental trophoblasts. Journal of Clinical Endocrinology and Metabolism 90 7 2005 4267 4275
29. I. Bildirici C.-R. Roh W. T. Schaiff B. M. Lewkowski D. M. Nelson Y. Sadovsky sadovskyy@msnotes.wustl.edu The lipid droplet-associated protein adipophilin is expressed in human trophoblasts and is regulated by peroxisomal proliferator-activated receptor-γ/Retinoid X Receptor. Journal of Clinical Endocrinology and Metabolism 88 12 2003 6056 6062
30. A. K. Duttaroy a.k.duttaroy@medisin.uio.no Fetal growth and development: roles of fatty acid transport proteins and nuclear transcription factors in human placenta. Indian Journal of Experimental Biology 42 8 2004 747 757
31. M. Lappas K. Yee M. Permezel G. E. Rice Lipopolysaccharide and TNF-α activate the nuclear factor kappa B pathway in the human placental JEG-3 cells. Placenta 27 2006 6-7 568 575
32. D. A. Kniss kniss.1@osu.edu Cyclooxygenases in reproductive medicine and biology. Journal of the Society for Gynecologic Investigation 6 6 1999 285 292
33. M. Lappas M. Permezel H. M. Georgiou G. E. Rice Regulation of proinflammatory cytokines in human gestational tissues by peroxisome proliferator-activated receptor-γ: effect of 15-deoxy-Δ 12,14 -PG J 2 and troglitazone. Journal of Clinical Endocrinology & Metabolism 87 2002 10 4667 4672
34. W. E. Ackerman X. L. Zhang B. H. Rovin D. A. Kniss Modulation of cytokine-induced cyclooxygenase 2 expression by PPARG ligands through NF κ B signal disruption in human WISH and amnion cells. Biology of reproduction 73 2005 3 527 535
35. E. B. Berry J. A. Keelan R. J. Helliwell R. S. Gilmour M. D. Mitchell Nanomolar and micromolar effects of 15-deoxy- Δ12,14-prostaglandin J 2 on amnion-derived wish epithelial cells: differential roles of peroxisome proliferator-activated receptors γ and δ and nuclear factor κB. Molecular Pharmacology 68 2005 1 169 178
36. M. Lappas mlappas@unimelb.edu.au G. E. Rice Phospholipase A 2 isozymes in pregnancy and parturition. Prostaglandins Leukotrienes and Essential Fatty Acids 70 2 2004 87 100
37. M. Lappas M. Permezel G. E. Rice Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via nuclear factor-κB, peroxisomal proliferator-activated receptor-γ and extracellularly regulated kinase 1/2. Endocrinology 146 2005 8 3334 3342
38. L. R. Dunn-Albanese W. E. Ackerman Y. Xie J. D. Iams D. A. Kniss Reciprocal expression of peroxisome proliferator-activated receptor-γ and cyclooxygenase-2 in human term parturition. American Journal of Obstetrics and Gynecology 190 2004 3 809 816
39. T. M. Lindstrom P. R. Bennett 15-Deoxy-Δ 12,14 -prostaglandin J 2 inhibits interleukin-1β-induced nuclear factor-κ b in human amnion and myometrial cells: mechanisms and implications. Journal of Clinical Endocrinology & Metabolism 90 2005 6 3534 3543
40. L. Capparuccia D. Marzioni A. Giordano PPARγ expression in normal human placenta, hydatidiform mole and choriocarcinoma. Molecular Human Reproduction 8 2002 6 574 579
41. J. M. Roberts R. N. Taylor T. J. Musci G. M. Rodgers C. A. Hubel M. K. McLaughlin Preeclampsia: an endothelial cell disorder. American Journal of Obstetrics and Gynecology 161 5 1989 1200 1204
42. D. Ware Branch M. D. Mitchell E. Miller W. Palinski J. L. Witztum Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein. Lancet 343 8898 1994 645 646
43. R. D. Johnson K. L. Polakoski X. Huang Y. Sadovsky D. M. Nelson The release of 15-hydroxyeicosatetraenoic acid by human placental trophoblast is increased in preeclampsia. American Journal of Obstetrics and Gynecology 178 1 part 1 1998 54 58
44. R. L. Schild W. T. Schaiff M. G. Carlson E. J. Cronbach D. M. Nelson Y. Sadovsky sadovskyy@msnotes.wustl.edu The activity of PPAR γ in primary human trophoblasts is enhanced by oxidized lipids. Journal of Clinical Endocrinology and Metabolism 87 3 2002 1105 1110
45. T. Fournier L. Pavan A. Tarrade The role of PPAR-γ/RXR-α heterodimers in the regulation of human trophoblast invasion. Annals of the New York Academy of Sciences 973 2002 26 30
46. J. A. Keelan T. A. Sato K. W. Marvin J. Lander R. S. Gilmour M. D. Mitchell 15-Deoxy-Δ12,14-prostaglandin J 2, a ligand for peroxisome proliferator-activated receptor-γ, induces apoptosis in JEG3 choriocarcinoma cells. Biochemical and Biophysical Research Communications 262 1999 3 579 585
47. J. Keelan R. Helliwell B. Nijmeijer 15-Δ12,14-prostaglandin J 2-induced apoptosis in amnion-like WISH cells. Prostaglandins and Other Lipid Mediators 66 2001 4 265 282
48. S.-Q. Kuang L. Liao H. Zhang Deletion of the cancer-amplified coactivator AIB3 results in defective placentation and embryonic lethality. Journal of Biological Chemistry 277 47 2002 45356 45360
49. K. Nadra S. I. Anghel E. Joye Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor β/δ Molecular and Cellular Biology 26 2006 8 3266 3281
50. L. Julan H. Guan J. P. Van Beek K. Yang kyang@uwo.ca Peroxisome proliferator-activated receptor δ suppresses 11β-hydroxysteroid dehydrogenase type 2 gene expression in human placental trophoblast cells. Endocrinology 146 3 2005 1482 1490
51. Y. Xu T. J. Cook G. T. Knipp Effects of di-(2-ethylhexyl)-phthalate (DEHP) and its metabolites on fatty acid homeostasis regulating proteins in rat placental HRP-1 trophoblast cells. Toxicological Sciences 84 2005 2 287 300
52. E. Capobianco A. Jawerbaum V. White C. Pustovrh D. Sinner E. T. Gonzalez elidate@fibertel.com.ar Elevated levels of endothelin-1 and prostaglandin E 2 and their effect on nitric oxide generation in placental tissue from neonatal streptozotocin-induced diabetic rats. Prostaglandins Leukotrienes and Essential Fatty Acids 68 3 2003 225 231
53. A. Jawerbaum E. Capobianco C. Pustovrh Influence of peroxisome proliferator-activated receptor γ activation by its endogenous ligand 15-deoxy Δ12,14 prostaglandin J 2 on nitric oxide production in term placental tissues from diabetic women. Molecular Human Reproduction 10 9 2004 671 676
54. A. Jawerbaum a.jawerbaum@abaconet.com.ar E. González Diabetic pregnancies: the challenge of developing in a pro-inflammatory environment. Current Medicinal Chemistry 13 18 2006 2127 2138
55. M. J. Willi M. Winkler D.-C. Fischer T. Reineke H. Maul W. Rath Chorioamnionitis: elevated interleukin-6 and interleukin-8 concentrations in the lower uterine segment. Journal of Perinatal Medicine 30 4 2002 292 296
56. V. Zaga G. Estrada-Gutierrez J. Beltran-Montoya R. Maida-Claros R. Lopez-Vancell F. Vadillo-Ortega felipe.vadillo@uia.mx Secretions of interleukin-1β and tumor necrosis factor α by whole fetal membranes depend on initial interactions of amnion or choriodecidua with lipopolysaccharides or group B streptococci. Biology of Reproduction 71 4 2004 1296 1302
57. B. Jacobsson I. Mattsby-Baltzer H. Hagberg Interleukin-6 and interleukin-8 in cervical and amniotic fluid: relationship to microbial invasion of the chorioamniotic membranes. Journal of Obstetrics and Gynaecology 112 6 2005 719 724
58. V. Zaga-Clavellina G. G. Lopez G. Estrada-Gutierrez Incubation of human chorioamniotic membranes with Candida albicans induces differential synthesis and secretion of interleukin-1β, interleukin-6, prostaglandin E 2, and 92 kDa type IV collagenase. Mycoses 49 2006 1 6 13
59. B. Toth bettina.toth@med.uni-muenchen.de D. Hornung C. Scholz S. Djalali K. Friese U. Jeschke Peroxisome proliferator-activated receptors: new players in the field of reproduction. American Journal of Reproductive Immunology 58 3 2007 289 310